Post-transplant lymphoproliferative disorders

1 Introduction ........................................................................................................ 1 Vikas R. Dharnidharka, Michael Green, and Steven Webber 2 Historical Perspective on the Early Studies of Posttransplant Lymphoproliferative Disorders (PTLD) ............................ 5 Douglas W. Hanto 3 Epidemiology of PTLD ...................................................................................... 17 Vikas R. Dharnidharka 4 The Biology of Epstein–Barr Virus and Posttransplant Lymphoproliferative Disease ........................................... 29 Olivia M. Martinez 5 Epstein–Barr Viral Load Testing: Role in the Prevention, Diagnosis and Management of Posttransplant Lymphoproliferative Disorders ........... 45 Jutta K. Preiksaitis 6 Clinical Features and Diagnostic Evaluation of Posttransplant Lymphoproliferative Disorder ........................................... 69 Upton D. Allen 7 Pathology ............................................................................................................ 89 Steven H. Swerdlow 8 Prognostic Factors for PTLD ............................................................................ 105 Tapan Maniar and Donald Tsai 9 Treatment of PTLD ............................................................................................ 117 Steven A. Webber x Contents 10 Prevention of Epstein–Barr Virus Infection and Posttransplant Lymphoproliferative Disease Following Transplantation ........................... 133 Michael Green and Marian Michaels 11.a Organ Specific Issues of PTLD – Kidney ..................................................... 145 Sophie Caillard 11.b Posttransplantation Lymphoproliferative Disorder (PTLD) in Liver and Small Bowel Transplant Recipients......................................... 153 Jaime Pineda and George V. Mazariegos 11.c Heart and Lung Transplantation .................................................................. 163 Silke Wiesmayr and Steven A. Webber 11.d Posttransplant Lymphoproliferative Disease (PTLD) in Hematopoietic Stem Cell Transplantation (HSCT) ................................. 173 Thomas G. Gross 12 Research Priorities and Future Directions ................................................... 183 Vikas R. Dharnidharka, Michael Green, and Steven A. Webber Index .......................................................................................................................... 187